Come up with a name for your new list and we'll add to it:
Apexian Pharmaceuticals raised a round of funding on June 16, 2013. Investors include
National Cancer Institute.
Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/R…